Cargando…
Deciphering the Contribution of BP230 Autoantibodies in Bullous Pemphigoid
Bullous pemphigoid (BP) is a subepidermal autoimmune blistering disease predominantly affecting elderly patients and carries significant morbidity and mortality. Patients typically suffer from severe itch with eczematous lesions, urticarial plaques, and/or tense blisters. BP is characterized by the...
Autores principales: | Cole, Connor, Borradori, Luca, Amber, Kyle T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326648/ https://www.ncbi.nlm.nih.gov/pubmed/35892704 http://dx.doi.org/10.3390/antib11030044 |
Ejemplares similares
-
Evaluation of ELISA BP180 and BP230 Autoantibodies in Blister Fluid and Serum in the Diagnosis of Bullous Pemphigoid
por: Nagarajan, Harish, et al.
Publicado: (2023) -
Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms
por: Cole, Connor, et al.
Publicado: (2022) -
Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody
por: Clapé, Ariane, et al.
Publicado: (2018) -
Evaluation of the Role of BIOCHIP Mosaic Based Indirect Immunofluorescence and ELISA BP 180 and BP 230 Autoantibodies in the Diagnosis of Bullous Pemphigoid Patients
por: Nithya, VPS, et al.
Publicado: (2022) -
A Cross-Sectional Study to Correlate Disease Severity in Bullous Pemphigoid Patients with Serum Levels of Autoantibodies Against BP180 and BP230
por: Muhammed, Naziya, et al.
Publicado: (2021)